Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade F 41.3 -1.29% -0.54
QURE closed down 1.29 percent on Friday, August 7, 2020, on 34 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical QURE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish -1.29%
20 DMA Resistance Bearish -1.27%
NR7 Range Contraction -1.27%
NR7-2 Range Contraction -1.27%
20 DMA Resistance Bearish -2.25%
1,2,3 Retracement Bearish Bearish Swing Setup -2.25%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.25%
NR7 Range Contraction -2.25%
Up 3 Days in a Row Strength -3.03%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Biopharmaceutical Biology Diseases Gene Therapy Genetics Parkinson's Disease Applied Genetics Gene Delivery Adeno Associated Virus Treatment Of Hemophilia AAV Lipoprotein Lipase Deficiency Acute Intermittent Porphyria Alipogene Tiparvovec Glybera

Is QURE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 76.6869
52 Week Low 36.2
Average Volume 667,681
200-Day Moving Average 56.42
50-Day Moving Average 51.40
20-Day Moving Average 41.95
10-Day Moving Average 40.92
Average True Range 2.26
ADX 36.02
+DI 15.11
-DI 29.00
Chandelier Exit (Long, 3 ATRs ) 41.73
Chandelier Exit (Short, 3 ATRs ) 43.26
Upper Bollinger Band 45.68
Lower Bollinger Band 38.22
Percent B (%b) 0.41
BandWidth 17.78
MACD Line -2.48
MACD Signal Line -3.20
MACD Histogram 0.7178
Fundamentals Value
Market Cap 1.06 Billion
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -14.65
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.85
Resistance 3 (R3) 43.93 43.17 43.43
Resistance 2 (R2) 43.17 42.52 43.13 43.28
Resistance 1 (R1) 42.23 42.12 41.85 42.15 43.14
Pivot Point 41.47 41.47 41.28 41.43 41.47
Support 1 (S1) 40.53 40.82 40.15 40.45 39.46
Support 2 (S2) 39.77 40.42 39.73 39.32
Support 3 (S3) 38.83 39.77 39.18
Support 4 (S4) 38.75